UK results from the myeloproliferative neoplasms (MPN) landmark survey on the symptom, emotional and economic burden of MPN

Br J Haematol. 2019 Aug;186(3):e1-e4. doi: 10.1111/bjh.15839. Epub 2019 Mar 10.

¹ Guy's and St.Thomas' NHS Foundation Trust, Guy's Hospital, London, UK.
² MPN Voice, London, UK.
³ Oxford NIHR Biomedical Research Centre, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.
⁴ Patient Advocacy Director, Leukaemia Care, Worcester, UK.
⁵ Hull Royal Infirmary, Hull, UK.
⁶ Nottingham University Hospital, Nottingham, UK.
⁷ Adelphi Real World, Bollington, UK.
⁸ Haematology Franchise, Novartis Pharmaceuticals UK Limited, Camberley, Surrey, UK.

No abstract available

Keywords: activities of daily living; myeloproliferative disorder; quality of life; symptom burden; work productivity.

Publication types